Market research has seen tremendous innovation in the past decade, but research techniques used for MESSAGE TESTING have not changed in a long time. It’s time message testing research got an upgrade.
Can-innovative-market-research-enhance-drug-launch-campaigns.pdfNewristics USA
Newristics is the first company to provide market research & message optimization services based on behavioral science & artificial intelligence. Our AI models are trained on more than 660 known heuristics.
Big data, RWE and AI in Clinical Trials made simpleHadas Jacoby
Technology is slowly but surely penetrating the healthcare industry in general and the clinical trials sector in particular. New and advanced solutions offer a variety of possibilities aimed to both improving existing processes and creating new and more efficient ones. And on top of all stands the desire to make clinical trials more patient centric.
In all of this, even though some of the technologies have yet to mature enough to meet the high quality standards necessary, it is important to know them and begin imagining the promise they hold for clinical trials.
can-ai-be-used-to-refresh-messaging-more-efficiently-for-pharma-brands.pdfNewristics USA
With the Pharma industry rapidly evolving, brand teams are realizing the need for more frequent message refreshes to stay ahead. But often marketing teams don’t have new clinical data or even customer insights to execute a message refresh. If you have nothing new to say, can you really say it differently enough to make a difference?
Can-innovative-market-research-enhance-drug-launch-campaigns.pdfNewristics USA
Newristics is the first company to provide market research & message optimization services based on behavioral science & artificial intelligence. Our AI models are trained on more than 660 known heuristics.
Big data, RWE and AI in Clinical Trials made simpleHadas Jacoby
Technology is slowly but surely penetrating the healthcare industry in general and the clinical trials sector in particular. New and advanced solutions offer a variety of possibilities aimed to both improving existing processes and creating new and more efficient ones. And on top of all stands the desire to make clinical trials more patient centric.
In all of this, even though some of the technologies have yet to mature enough to meet the high quality standards necessary, it is important to know them and begin imagining the promise they hold for clinical trials.
can-ai-be-used-to-refresh-messaging-more-efficiently-for-pharma-brands.pdfNewristics USA
With the Pharma industry rapidly evolving, brand teams are realizing the need for more frequent message refreshes to stay ahead. But often marketing teams don’t have new clinical data or even customer insights to execute a message refresh. If you have nothing new to say, can you really say it differently enough to make a difference?
SCOPE 2015: Online Communities & Mobile Communication Impact on Recruitment ...Imperial CRS
In a joint presentation with Dennis Upah of Remedy Health Media, Melynda Geurts of DAC Patient Recruitment Services discusses the impact of online communities and mobile communication on patient recruitment and retention for clinical trials.
Customer Experience (CX) in Physician and HCP EngagementMarketResearch.com
Customer Experience Management: What are the essential ingredients for delivering a successful CX programme?
All in it together? There is a tendency for pharma to think in silos - how can this be challenged to deliver coherent company-wide customer communications?
Same goal, different needs: How can pharma meet the differing content and communication preferences of physicians and other healthcare professionals?
Something different: How will high levels of customer satisfaction differentiate your product in a crowded market place and encourage wider use?
Getting it wrong: Why do so many digital initiatives fail to engage physicians and HCPs?
Wider support: How can stakeholders work with pharma to create a mutually beneficial customer experience?
Sample size is one of many factors to consider when designing a survey for consumer or B2B research. Leveraging best practices in statistics and research design, this white paper examines how to plan sampling strategy for research studies, ensuring that results are accurate and meaningful for your organization.
Clinical trials are necessary for medical research. Producing new medicines to the market depends on the strength of research organizations and drug companies to test and verify their work vigorously through their Clinical Trials, but finding people willing to participate is notoriously tricky.
The convergence of separate health systems has led to
a great increase in data, which some organisations are
struggling to get to grips with. Harnessing analytic tools
and sharing knowledge is the best way forward
Questions1. To what extent do you consider the title adequately re.pdfAlphaVision2
Questions
1. To what extent do you consider the title adequately represents the research question and
research objectives?(5 points)
2. To what extent do you consider the literature discussed in the Background section supports the
research question and objectives? Give reasons for your answer. (5 points)
3. In relation to the title, research question and research objectives, what key points would you
wish to outline in a revised Background section? (5 points)
4. What are the strengths and weaknesses of the information provided in the Method, Timescale
and Resources sections? (5 points)
5. What key points would you wish to emphasise in revised Method, Timescale and Resources
sections? (5 points)
6. Proofread Katrinas draft proposal and make a list of all the spelling, typographical and
referencing errors you can find. (5 points)
Task 3:
Kristinas first draft research proposal
Kristina is studying for a masters degree in international business, Although she has chosen to
study overseas, she wishes to undertake her research project in her home country. She is
interested in the relationship between marketing strategy and international business and has
prepared her research proposal for an applied research project. This states that the aim of her
research project is to establish how the case study organisation (Healthy-FoodCo) can market a
dietary supplement (DietSupp) successfully in another country (OverSeasCountry). She emails
the first draft of her research proposal to her project supervisor and is surprised that he emails
back, requesting a meeting to talk through some concerns about the proposal. Below we present
an abbreviated version of the first draft of her research proposal. Please note the proposal
intentionally includes methodological, as well as spelling and grammatical, errors to allow you to
evaluate and improve it by working through the case study questions.
Title
The impact of national cultures and the marketing mix on consumer buying behaviour: A case
study of HealthyFoodCos marketing of a new diet supplement internationally.
Background (abridged)
The marketing mix is the central concept of marketing (Khan, 2014). Scholars argue that the
concept originated in the 1940s with Neil Borden (e.g. Schultz and Dev, 2012). At this point, the
concept of marketing mix was not formally defined and it was Jerome McCarthy who adapted
this concept in the 1950s into what is known as the 4Ps: product, price, place and promotion
(Schultze and Dev, 2012). Phillip Kotler then popularized the 4Ps (Schultz and Dev,2012),
which continue to be the most enduring marketing mixer framework. Each of the 4Ps may be
seen to be a controllable element that an organisation may use to formulate and implement a
marketing strategy that is adapted to the environment within which their target market exists
(Dadzie et alia 2017). The intention here is to influence customer buying behaviour favourably
towards the product being marketed.
However, as main critique surr.
n early 2020, when the novel coronavirus began to spread around the world, it became increasingly clear that the most effective way to combat the raging pandemic would be for the majority of the population to develop immunity — whether through natural infection or vaccination.
the-impact-of-social-media-on-mental-health.pdfNewristics USA
This whitepaper explores the decision heuristics that lead to completely irrational user behaviors, pertaining to the consumption and internalization of social media and its constant barrage of perfectly filtered photos, exaggerated lifestyles, and skewed validations.
More Related Content
Similar to transforming-message-testing-in-pharmaceutical-research.pdf
SCOPE 2015: Online Communities & Mobile Communication Impact on Recruitment ...Imperial CRS
In a joint presentation with Dennis Upah of Remedy Health Media, Melynda Geurts of DAC Patient Recruitment Services discusses the impact of online communities and mobile communication on patient recruitment and retention for clinical trials.
Customer Experience (CX) in Physician and HCP EngagementMarketResearch.com
Customer Experience Management: What are the essential ingredients for delivering a successful CX programme?
All in it together? There is a tendency for pharma to think in silos - how can this be challenged to deliver coherent company-wide customer communications?
Same goal, different needs: How can pharma meet the differing content and communication preferences of physicians and other healthcare professionals?
Something different: How will high levels of customer satisfaction differentiate your product in a crowded market place and encourage wider use?
Getting it wrong: Why do so many digital initiatives fail to engage physicians and HCPs?
Wider support: How can stakeholders work with pharma to create a mutually beneficial customer experience?
Sample size is one of many factors to consider when designing a survey for consumer or B2B research. Leveraging best practices in statistics and research design, this white paper examines how to plan sampling strategy for research studies, ensuring that results are accurate and meaningful for your organization.
Clinical trials are necessary for medical research. Producing new medicines to the market depends on the strength of research organizations and drug companies to test and verify their work vigorously through their Clinical Trials, but finding people willing to participate is notoriously tricky.
The convergence of separate health systems has led to
a great increase in data, which some organisations are
struggling to get to grips with. Harnessing analytic tools
and sharing knowledge is the best way forward
Questions1. To what extent do you consider the title adequately re.pdfAlphaVision2
Questions
1. To what extent do you consider the title adequately represents the research question and
research objectives?(5 points)
2. To what extent do you consider the literature discussed in the Background section supports the
research question and objectives? Give reasons for your answer. (5 points)
3. In relation to the title, research question and research objectives, what key points would you
wish to outline in a revised Background section? (5 points)
4. What are the strengths and weaknesses of the information provided in the Method, Timescale
and Resources sections? (5 points)
5. What key points would you wish to emphasise in revised Method, Timescale and Resources
sections? (5 points)
6. Proofread Katrinas draft proposal and make a list of all the spelling, typographical and
referencing errors you can find. (5 points)
Task 3:
Kristinas first draft research proposal
Kristina is studying for a masters degree in international business, Although she has chosen to
study overseas, she wishes to undertake her research project in her home country. She is
interested in the relationship between marketing strategy and international business and has
prepared her research proposal for an applied research project. This states that the aim of her
research project is to establish how the case study organisation (Healthy-FoodCo) can market a
dietary supplement (DietSupp) successfully in another country (OverSeasCountry). She emails
the first draft of her research proposal to her project supervisor and is surprised that he emails
back, requesting a meeting to talk through some concerns about the proposal. Below we present
an abbreviated version of the first draft of her research proposal. Please note the proposal
intentionally includes methodological, as well as spelling and grammatical, errors to allow you to
evaluate and improve it by working through the case study questions.
Title
The impact of national cultures and the marketing mix on consumer buying behaviour: A case
study of HealthyFoodCos marketing of a new diet supplement internationally.
Background (abridged)
The marketing mix is the central concept of marketing (Khan, 2014). Scholars argue that the
concept originated in the 1940s with Neil Borden (e.g. Schultz and Dev, 2012). At this point, the
concept of marketing mix was not formally defined and it was Jerome McCarthy who adapted
this concept in the 1950s into what is known as the 4Ps: product, price, place and promotion
(Schultze and Dev, 2012). Phillip Kotler then popularized the 4Ps (Schultz and Dev,2012),
which continue to be the most enduring marketing mixer framework. Each of the 4Ps may be
seen to be a controllable element that an organisation may use to formulate and implement a
marketing strategy that is adapted to the environment within which their target market exists
(Dadzie et alia 2017). The intention here is to influence customer buying behaviour favourably
towards the product being marketed.
However, as main critique surr.
n early 2020, when the novel coronavirus began to spread around the world, it became increasingly clear that the most effective way to combat the raging pandemic would be for the majority of the population to develop immunity — whether through natural infection or vaccination.
the-impact-of-social-media-on-mental-health.pdfNewristics USA
This whitepaper explores the decision heuristics that lead to completely irrational user behaviors, pertaining to the consumption and internalization of social media and its constant barrage of perfectly filtered photos, exaggerated lifestyles, and skewed validations.
understanding-Opioid-Crisis-using-decision-heuristics-science.pdfNewristics USA
This paper explores the Opioid Epidemic in an entirely new light. It puts the spotlight on a string of human decisions that triggered major market-shaping events that ultimately led to the Opioid Crisis in America.
How-did-medical-errors-becaome-the-cause-of-death-in-the-us.pdfNewristics USA
It's scary to think that your Healthcare may kill you. But that indeed is the unfortunate truth for tens of thousands of Americans, whose deaths are direct results of medical errors. While the issue is multi-faceted and involves several stakeholders, mitigating medical errors requires a closer look at the behavioral drivers involved.
In early 2020, when the novel coronavirus began to spread around the world, it became increasingly clear that the most effective way to combat the raging pandemic would be for the majority of the population to develop immunity — whether through natural infection or vaccination. After months of tireless effort, now that the vaccine has become a reality, we still find people hesitant to vaccinate.
social_media_impact_on_mental_health_new01.pdfNewristics USA
Newristics is the first company to provide market research & message optimization services based on behavioral science & artificial intelligence. Our AI models are trained on more than 660 known heuristics.
Newristics is the first company to provide market research & message optimization services based on behavioral science & artificial intelligence. Our AI models are trained on more than 660 known heuristics.
Newristics is the first company to provide market research & message optimization services based on behavioral science & artificial intelligence. Our AI models are trained on more than 660 known heuristics.
a-futuristic-approach-to-message-testing-for-pharma-companies.pdfNewristics USA
Newristics is the first company to provide market research & message optimization services based on behavioral science & artificial intelligence. Our AI models are trained on more than 660 known heuristics.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
1. A Futuristic Approach to
Message Testing for Pharma Companies
Why the science behind message testing needs
a serious upgrade and what is the future of
message testing?
Reinventing
Message
Testing
2. WHY PHARMA NEEDS A STEP CHANGE IN MESSAGE TESTING
In the last decade, the pharma industry has gone through significant changes in how it messages
to physicians, patients and payers. The processes and tools that pharma brands use to DEVELOP
and DELIVER messages have been disrupted by new technologies. However, what hasn’t
changed much is the TESTING of messages in market research prior to execution.
It is still too common for brands to test messages in qualitative IDIs despite the known
shortcomings of qualitative research. In fact, entire message campaigns can be decided based
on 20-30 qualitative interviews, campaigns that are supported by $10-100 millions in spending!
Even when brands use quant message testing, conventional methodologies like maxdiff/TURF
haven't evolved in decades and still have many shortcomings.
2
With little innovation in message testing research, even
The most basic needs have not been met.
Still can’t test a lot
of messages in one
study
Still have to ask
stated questions
about why like/dislike
Still can’t improve
messages as
you test
Still can’t get better
separation in
message scores
Still focus on top
messages, not
message storyflow
Still can’t get
best messages
by channel
3. An industry wide study on the Future of Messaging commissioned jointly by
Intellus Worldwide and Newristics highlights the urgent need for advanced
message testing optimization methodologies in pharma.
Messaging will shift dramatically
in the future: from clinical to
RWE/PRO, from rational to
emotional, biomarker testing,
companion, diagnostics, etc.
HEOR/HECON teams will heavily
influence message development
in the future as increasingly more
messages will be targeted towards
IDNs and hospital networks.
Development
Testing
Performance
Message story flow will become
more important than the core
message bundle, as detailing
shifts from data-telling to
storytelling.
Execution
Non-personal promotion channels
will grow in importance in the
future as more physician practices
and their affiliates limit rep access.
Messaging research will shift
from traditional qual/quant to
micro-surveys, usability testing,
machine learning, etc.
In market message testing will
become more common than
market research testing,
driven by need for faster
message refresh cycles.
Customization message story
flow by channel and by customer
segments will become more of
the norm vs the aspiration.
Messaging campaigns will be
refreshed more frequently,
triggered by more frequent data
releases and agile sales
technology.
Emerging Metrics such as
brand sentiment and formulary
access will become key
measure of success.
Real-time ROI measurement and
campaign optimization will
replace traditional pre-post
campaign ROI analysis.
New message recall assessment
techniques will likely displace
traditional methods.
Message development will be
pushed earlier in the commercial
launch planning process.
$
3
4. Traditional Qualitative Message Testing (IDIs/TDIs)
How It Works
Qualitative research is used extensively in the pharmaceutical industry to test messages with
customers (HCPs, Patients, and Payers).
1
Typically, messages are tested
qualitatively in 1-on-1 interviews
lasting 60 mins (IDI/TDIs).
3
After every message exposure,
respondents are asked to score the
message and “talk” about the
rationale for their score.
5
Prioritized messages from each
attribute are shown again to
respondents and they are asked to
organize the messages in a story flow.
2
Messages are organized into
attributes like Efficacy, Safety, MOA
etc. and are exposed to respondents
one message at a time.
4
The moderator probes on what
respondents like/dislike in each
message and tries to capture ideas
for improving each message.
4
5. Limitations of the Traditional Qualitative Approach
Traditional qualitative message testing has many limitations and should, ideally, no longer be
used in the pharma industry. Yet, tens of millions of valuable market research dollars are spent
every year by pharma brands to test messages qualitatively.
It is not representative of the real world
and makes respondents artificially pay
attention to messages.
Feedback from outliers is neglected even
though there are many outliers in the real
world.
Improvements suggested by respondents
are rarely useful since they are not
marketers.
Only a small number of messages can be
tested, forcing brands to make tough
choices on what to test.
Respondent feedback to messages is all
‘stated’ and there are no derived insights.
There is little or no differentiation in
message scores or regression to the
mean for all the messages.
Bad solution for message bundling/storyflow
– too many combinations are unexplored.
1
2
3
4
5
6
7
5
6. Traditional Quant Message Testing (Maxdiff/TURF)
How It Works
Traditional quantitative message testing methodologies use choice-based models like
conjoint, discrete choice or Maxdiff/TURF.
2 Choices can be individual messages
or message bundles.
3
Each respondent sees 45-80 choices,
but they are not all unique.
Some choices are tested more than
once with the same respondent.
4
Since there are more choices possible than
what can be shown, a Design of Experiments
(DOE) is created to make sure that enough
choices are tested and each choice is tested
with enough respondents.
5
Utility scores are aggregated for each
message based on data from the
respondents and are used to create a
message hierarchy.
1
Take respondents through 15-20
choice sets containing 3-4
messages in every choice set.
6
7. Limitations of the Traditional Quantitative Approach
Traditional choice-based methodologies also have some known limitations that create
challenges for message testing:
When message bundles are tested, scores for
individual messages have to be modeled, which is
also not ideal because many messages end up
having similar scores.
Traditional methodologies don’t provide feedback on
why messages do/don’t do well in research and how
to improve them.
If individual messages are tested, then message
bundles have to be modeled with a simulator, which
is not ideal because interaction effects between
messages are not adequately accounted for.
The design of experiments does not take into
account individual respondent-level choice drivers,
which means that irrelevant choices could be tested
with many respondents in many choice sets.
1
2
The Design of Experiments approach works well with up
to 30-40 messages, after which, either respondents have
to be shown an overwhelming number of choices or the
sample size has to be increased.
3
4
5
7
8. Heuristics-Based Message Testing: A futuristic approach
Decision heuristics science or behavioral science offers a novel approach to market research
in general, and many use case scenarios for behavioral science in market research have emerged
in the past few years. From deep insights research to patient journey to idea testing to brand health,
decision heuristics science can be incorporated into almost every type of customer research.
Physicians and patients don’t
realize that they are using
heuristics to make decisions
and don’t offer them as
explanations for their
behaviors.
Many of the heuristics are
cognitive biases, judgment
fallacies, psychological or
social effects and can even
lead to irrational decisions
when used very quickly.
Decision heuristics are
mental shortcuts that drive
human decisions. In every
therapeutic area, there is a
set of dominant decision
heuristics that drive most of
the treatment decisions.
Decision heuristics have been
discovered by conducting
behavioral experiments that
are designed to put people
under certain predetermined
situations and then track their
behaviors/choices.
The choices can be powered
by heuristics, and respondent
behaviors during the research
can be tracked to study the
underlying heuristics.
Decision heuristics science is
ideally suited for market
research in which the
respondents are shown a
series of choices.
What is decision heuristics science?
Decision heuristics science sheds light on how
humans behave in real life and research.
?
8
9. Decision heuristics science is a great tool to test messages with respondents in a new
“behavioral” way to optimize messages AND message bundles, based on how they make
treatment decisions.
Heuristics-based message testing overcomes many of the limitations that plague traditional
methodologies:
A Large number of
messages can be tested
without a large sample
because heuristics can be
used to create the design
of experiments.
Choices are presented to
respondents based on
how they make decisions
using specific decision
heuristics, which means
their exposures are much
more relevant.
Heuristic preferences
can provide real-time
intelligence on
respondents during the
survey that can be used
to make real-time
predictions.
Drivers of message appeal
can be estimated through
the language that talks to
decision heuristics in each
message, eliminating the
need for asking stated
diagnostics survey
questions that can also be
very time consuming.
Using decision heuristics science for message testing
Benefits of the Heuristics-Based Approach
b. Customize messages to each
respondent based on their
heuristic preferences, forcing them
to provide greater distinction
between choices.
b. Develop alternative versions
of each message using the best-fit
heuristic and test both the
alternatives and the originals in
research.
a. Use language in each
message as a signal for decision
heuristics and tag each message
in the inventory with the “best-fit”
decision heuristic.
a. Test not just the appeal of
messages, but also the appeal of
underlying heuristics embedded in
the language of each message.
b. Go beyond a Message
Hierarchy and a TURF analysis
and optimize the precise message
bundles and story flow for all
messaging channels.
a. Feed data from respondents
into advanced machine learning
algorithms that identify the best
combination of any number of
messages based on heuristics.
After Research
Before Research During Research
9
10. CMO is the first and only message testing algorithm that combines the power of behavioral
science and artificial intelligence to test messages with customers in a way that can propel the
future of marketing in pharma.
Designed with 3 years of pure R&D, CMO is built exclusively to test messaging in the pharma
industry and offers benefits that every pharma marketer and market researcher will need in the
future.
CMO (Choose Message Optimizer)
Message Testing for the Future of Marketing
CMO cuts the time it takes
to go from the 1st draft of
messages to campaign
development by 65% and
save up to 15 weeks.
CMO cuts the total cost of
testing messages by 50% or
more.
CMO is proven superior to
even the most advanced
message testing methodologies
in identifying the optimal
message bundle from the same
inventory of messages.
CMO simplifies the process
of testing and optimizing
messages before launch.
Faster
Cheaper
Better
Easier
a. CMO can test 100s of messages, which eliminates the need for your
team to spend time prioritizing messages before research.
b. CMO creates “heuristicized” alternative versions of your messages
before research, and tests both the original and heuristicized versions
with respondents.
c. CMO delivers optimal message bundles that are campaign ready for
omni-channel use, saving time needed for execution.
a. CMO can potentially eliminate all qualitative message testing
because the heuristics-based design of CMO provides the WHY
behind the appeal of each message without having to ask
respondents.
b. CMO can even eliminate draft paper vis-aid testing because data
from the CMO study can identify the optimal message bundle for
every page of the vis-aid.
a. CMO message bundle was preferred by 1.5x more people.
b. CMO message bundle had 25% higher Utility Scores.
c. CMO message bundle had statistically higher scores for diagnostics
like Believability, Relevance, Uniqueness and Likelihood to Use.
a. Turnkey: all you need to provide is the draft inventory of messages
for testing.
b. Minimal project management is needed from your team.
c. CMO eliminates rounds of unproductive meetings and workshops
needed to review, refine and prioritize messages.
10
11. CMO Research on Research
The superiority of CMO was studied in a large-scale meta-analysis of research projects
11
29 22 4,752
20 6,420 36
research projects product categories messages tested
leading brands respondents months
CMO is proven to identify winning messaging for brands
through market research
100% of CMO projects
resulted in improvement
vs. current messaging and
vs. competitors
CMO-identified message
bundles had 1.7 times
higher customer
preference than current
in-market messaging
CMO message bundles
helped 7 out of 10
brands take or extend
market leadership and the
remaining brands close
gap vs. the leader
100%
Success Rate
1.7x
Improvement
Market
Leadership
Results based on comparison of preference share data on message bundles from the 29 studies
12. CMO has a 100% success rate
The preference share of CMO-generated message bundles was higher
than current in-market message bundles in 100% of the studies
18%
14%
23%
18%
48%
33%
40%
35%
44%
42%
43%
32%
39%
30%
50%
56%
63%
55%
45%
57%
63%
51%
50%
57%
51%
60%
60%
79%
80%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
Current Message Bundle CMO-Generated Message Bundle
CMO vs. current message
bundle preference share
CMO improved preference share by 1.7x vs. current in-market messaging
CMO helped brands improve market leadership position with winning messages
CMO message bundles helped 7 out of 10 brands take or extend market leadership
and the remaining brands close gap vs. the leader
267%
14%
15%
15%
17%
20%
21%
28%
28%
33%
33%
35%
54%
56%
61%
63%
73%
75%
76%
81%
82%
84%
87%
96%
98%
106%
129%
149%
153%
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
Average improvement
in preference share
across 29 studies
71%
12
Current Messages
Optimized Bundle
Leading Competitor
3 out of 10 brands closed the gap
7 out of 10 brands extended/took the lead
e
r
a
h
S
e
c
n
e
r
e
f
e
r
P